Business
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ALNY, MGTI, HAS and CPB
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ALNY, MGTI, HAS and CPB.
About this update from Mgt Capital Investments, Inc.
[{"type":"text","content":"\nNEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.\n TG Therapeutics, Inc. (NASDAQCM: TGTX) Class Period: June 4, 2018 to September 25, 2018 Lead Plaintiff Deadline: December 3, 2018 The lawsuit alleges TG Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival. Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3 Alnylam Pharmaceuticals, Inc. (NASDAQGS: ALNY) Class Period: February 15, 2018 to September 12, 2018 Lead Plaintiff Deadline: November 26, 2018 The complaint alleges that during the class period Alnylam Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times. Get additional information about the ALNY lawsuit: http://www.kleinstocklaw.com/pslra-1/alnylam-pharmaceuticals-inc-loss-submission-form?wire=3 MGT Capital Investments Inc. (OTCMKTS: MGTI) Class Period: October 9, 2015 to September 7, 2018 Lead Plaintiff Deadline: November 27, 2018 MGT Capital Investments Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (2) the \"Scheme Defendants\"--Defendants Ladd, Honig, St...